Best practices in dengue surveillance: a report from the Asia-Pacific and Americas Dengue Prevention Boards.
Best practices in dengue surveillance: a report from the Asia-Pacific and Americas Dengue Prevention Boards.
复制标题
DOI：
10.1371/journal.pntd.0000890
复制
发表时间：
2010-11-16
影响因子：
3.8
通讯作者：
Asia-Pacific and Americas Dengue Prevention Boards Surveillance Working Group
中科院分区：
文献类型：
--
作者：
Beatty ME;Stone A;Fitzsimons DW;Hanna JN;Lam SK;Vong S;Guzman MG;Mendez-Galvan JF;Halstead SB;Letson GW;Kuritsky J;Mahoney R;Margolis HS;Asia-Pacific and Americas Dengue Prevention Boards Surveillance Working Group
登革热是一种由埃及伊蚊传播的病毒感染，可导致严重疾病，特别是儿童。登革热是世界上热带和亚热带地区的一个主要问题。我们邀请了来自世界各地的登革热专家参加会议，讨论登革热监测问题。我们回顾了文献，听取了关于监测项目的详细报告，并分享了专家的意见。在为期两天半的会议上，听取了22个国家的发言。我们描述了一般的最佳监测方法，登革热监测的利益相关者，以及从蚊子叮咬到报告登革热病例的步骤，以探索如何最好地进行登革热监测。我们还提供了详细信息和比较登革热监测计划的国家。专家们提出了建议，以获得登革热监测的最佳数据，接受真实的世界的现实（例如，有限的资金和人员）。他们的建议包括：（1）每个登革热流行国家都应强制向政府报告登革热病例;（2）应开发和使用电子报告系统;（3）登革热监测数据至少应包括按年龄组划分的发病率、住院率和死亡率;（4）应完成额外的研究，以检查系统的敏感性;（5）实验室应共享专业知识和数据;（6）对发烧4天或4天以内的病人应进行登革热病毒检测，4天后应进行抗体检测，以诊断登革热;（7）及早发现和预测登革热疫情应成为国家监测系统的目标。儿童登革热疫苗倡议在亚太和美洲区域组织了登革热预防委员会，由流行国家的登革热专家组成。两个委员会都召开了会议，审查监督方面的问题。通过演讲、促进讨论和调查，委员会确定了登革热监测的最佳实践，包括：（1）登革热应成为流行国家的一种须报告疾病;（2）应一致地应用世界卫生组织区域病例定义;（3）应开发并广泛使用电子报告系统，以加快向利益相关者提供数据;（4）最低限度的报告应包括登革热、登革出血热、登革休克综合征和登革死亡的发病率，住院率和死亡率应按年龄组报告;（5）定期进行额外研究（例如，（a）应当开展监测（捕获/重新捕获），以评估发现不足、报告不足和监测质量;（b）应当使实验室方法和规程标准化;（c）国家主管部门应当鼓励实验室建立网络，分享专门知识和数据; RT-PCR和病毒分离（以及可能检测NS 1蛋白）是确认急性登革热感染的推荐方法，但仅推荐用于发热发作后的4天-第4天后，推荐使用IgM捕获酶联免疫吸附试验。
Dengue fever is a virus infection that is spread by the Aedes aegypti mosquito and can cause severe disease especially in children. Dengue fever is a major problem in tropical and sub-tropical regions of the world. We invited dengue experts from around the world to attend meetings to discuss dengue surveillance. We reviewed literature, heard detailed reports on surveillance programs, and shared expert opinions. Presentations by 22 countries were heard during the 2.5 day meetings. We describe the best methods of surveillance in general, the stakeholders in dengue surveillance, and the steps from mosquito bite to reporting of a dengue case to explore how best to carry out dengue surveillance. We also provide details and a comparison of the dengue surveillance programs by the presenting countries. The experts provided recommendations for achieving the best possible data from dengue surveillance accepting the realities of the real world (e.g., limited funding and staff). Their recommendations included: (1) Every dengue endemic country should make reporting of dengue cases to the government mandatory; (2) electronic reporting systems should be developed and used; (3) at minimum dengue surveillance data should include incidence, hospitalization rates, deaths by age group; (4) additional studies should be completed to check the sensitivity of the system; (5) laboratories should share expertise and data; (6) tests that identify dengue virus should be used in patients with fever for four days or less and antibody tests should be used after day 4 to diagnose dengue; and (7) early detection and prediction of dengue outbreaks should be goals for national surveillance systems. The Pediatric Dengue Vaccine Initiative organized Dengue Prevention Boards in the Asia-Pacific and the Americas regions consisting of dengue experts from endemic countries. Both Boards convened meetings to review issues in surveillance. Through presentations, facilitated discussions, and surveys, the Boards identified best practices in dengue surveillance including: (1) Dengue should be a notifiable disease in endemic countries; (2) World Health Organization regional case definitions should be consistently applied; (3) electronic reporting systems should be developed and used broadly to speed delivery of data to stakeholders; (4) minimum reporting should include incidence rates of dengue fever, dengue hemorrhagic fever, dengue shock syndrome, and dengue deaths, and hospitalization and mortality rates should be reported by age group; (5) periodic additional studies (e.g., capture/recapture) should be conducted to assess under-detection, under-reporting, and the quality of surveillance; (6) laboratory methods and protocols should be standardized; (7) national authorities should encourage laboratories to develop networks to share expertise and data; and (8) RT-PCR and virus isolation (and possibly detection of the NS1 protein) are the recommended methods for confirmation of an acute dengue infection, but are recommended only for the four days after onset of fever—after day 4, IgM-capture enzyme-linked immunosorbent assay is recommended.
登录
查看更多内容
影响因子：
158.5
作者：
Reichert, TA;Sugaya, N;Tashiro, M
通讯作者：
Tashiro, M
影响因子：
8.8
作者：
Chanama, S;Anantapreecha, S;Sawanpanyalert, P
通讯作者：
Sawanpanyalert, P
DOI：
10.1590/s0102-311x2009001300011
发表时间：
2009-01-01
期刊：
Cadernos de Saúde Pública
影响因子：
--
作者：
Ooi, Eng-Eong;Gubler, Duane J.
通讯作者：
Gubler, Duane J.
影响因子：
12.7
作者：
Rigau-Pérez, JG;Millard, PS;Casta-Vélez, A
通讯作者：
Casta-Vélez, A
影响因子：
11.8
作者：
Krause G;Ropers G;Stark K
通讯作者：
Stark K